| Literature DB >> 19190337 |
Zhuohan Zhang1, Bin Zeng, Zhiqian Zhang, Guohui Jiao, Haijie Li, Zhizi Jing, Jiangbo Ouyang, Xin Yuan, Limin Chai, Yongzhe Che, Yuan Zhang, Rongcun Yang.
Abstract
Suppressor of cytokine signaling 3 (SOCS3) expression in bone marrow cells (BMC) was up-regulated upon exposure to interleukin 6, lipopolysaccharide, or tumor-associated factors. But, how the up-regulated SOCS3 affects differentiation of BMCs is incompletely characterized. Here, we showed that SOCS3 promoted BMCs to intently differentiate into CD8 T cells. Importantly, lung can be as one athymus tissue for the BMCs to differentiate into CD8(+) T cells. Notch1 plays a critical role in the differentiation from SOCS3-transfected BMCs to CD8(+) T cells. We conclude that the up-regulated SOCS3 in some pathologic conditions, such as tumor and inflammation, might promote BMCs to differentiate into CD8(+) T lymphocytes in lung tissue via up-regulating Notch1 expression. This may represent a new mechanism against diseases such as tumor.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19190337 DOI: 10.1158/0008-5472.CAN-08-2744
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701